AgeX Therapeutics logo
AgeX Therapeutics AGE

Quarterly report 2025-Q3
added 11-13-2025

report update icon

AgeX Therapeutics DSO Ratio 2011-2026 | AGE

Annual DSO Ratio AgeX Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
78.4 156 445 67.3 76.7 34.3 - 67.5 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
445 34.3 132

Quarterly DSO Ratio AgeX Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - 115 78.2 15.2 - 65.9 45.6 228 - 66.5 72.8 305 - 431 661 353 - 80.6 87.2 58.1 - 31.5 25.8 45.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
661 15.2 154

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Altimmune Altimmune
ALT
7.85 K $ 3.5 4.64 % $ 308 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
132 $ 221.52 -0.16 % $ 5 B danmarkDanmark
Heron Therapeutics Heron Therapeutics
HRTX
198 $ 0.8 2.5 % $ 133 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Incyte Corporation Incyte Corporation
INCY
66.6 $ 90.82 0.04 % $ 17.7 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
InMed Pharmaceuticals InMed Pharmaceuticals
INM
3.83 $ 0.79 -3.52 % $ 1.93 M canadaCanada
INmune Bio INmune Bio
INMB
60.1 K $ 1.23 5.13 % $ 22.1 M usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
1.91 K $ 1.57 -0.95 % $ 34.8 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
28.8 - -10.95 % $ 876 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
65.5 - -7.23 % $ 13 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
60.8 $ 2.13 1.91 % $ 199 M israelIsrael
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
475 $ 16.93 -0.41 % $ 841 M britainBritain
CorMedix CorMedix
CRMD
130 $ 6.35 1.6 % $ 457 K usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
31.5 $ 4.33 2.12 % $ 719 M canadaCanada
Kamada Ltd. Kamada Ltd.
KMDA
103 $ 8.33 0.97 % $ 260 M israelIsrael